News & Events
t2cure’s cell therapy is available through cooperating clinical centres
t2cure cooperates with experienced partners in research and in the industry.
t2cure's pipeline is built on clinical studies in cardiac and peripheral vascular indications
t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics.
At present, no new articles are available.